by Jakub Jarolím, Business Intelligence Department
SOTIO Biotech
2/5/2021
by Jakub Jarolím, Business Intelligence Department
Market
The Nasdaq Biotech Index added 4 % during April after a drop experienced in March. The index is however still 10 % below its maximum from February this year. Numerous companies presented their new data during virtual AACR conference.
Prostate Cancer
Nivolumab-ipilimumab combination demonstrates antitumor activity in prostate cancer subset. A combination of nivolumab and ipilimumab induced significant antitumor activity among men with metastatic castration-resistant prostate cancer and a positive immunogenic signature, according to results of the phase 2 NEPTUNES trial.
Ovarian Cancer News
FDA approved theinitiation of endoxifenstudy in OVCA. A patient with ovarian cancer has begun treatment with oral endoxifen, an active metabolite of tamoxifen, after a Safe to Proceed Letter was granted by the FDA, according to a press release by Atossa Therapeutics.
Lung Cancer News
AstraZeneca's lung cancer drug approved in China: AstraZeneca said that its Tagrisso medicine has been approved in China for the treatment of early lung cancer. The UK-based pharmaceutical giant said Tagrisso is the first such drug to have received approval in China, as well as the only one to have shown efficacy against the disease in a global trial.
Sdílet na sociálních sítích